Title:
DIHYDROARTEMISININ DIPLOID DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION
Document Type and Number:
WIPO Patent Application WO/2018/157874
Kind Code:
A1
Abstract:
Disclosed are a dihydroartemisinin diploid derivative, a pharmaceutical composition thereof, and an application. The derivative is an artemisinin diploid, used for drugs treating or preventing malaria caused by plasmodium, drugs treating autoimmune diseases such as lupus erythematosus, and anti-tumour drugs, which are pharmaceutical compositions made from the dihydroartemisinin diploid derivative and a pharmaceutically acceptable carrier.
More Like This:
| JPWO2013100018 | Heterocyclic compound |
| JP2023539198 | MCL-1 inhibitor formulation |
| JP2014141516 | NITROGEN-CONTAINING SPIRO RING COMPOUND AND ITS MEDICAL APPLICATION |
Inventors:
LI XINSONG (CN)
SI MA (CN)
LING LONGBING (CN)
SI MA (CN)
LING LONGBING (CN)
Application Number:
PCT/CN2018/082649
Publication Date:
September 07, 2018
Filing Date:
April 11, 2018
Export Citation:
Assignee:
UNIV SOUTHEAST (CN)
International Classes:
C07D519/00; A61K31/357; A61K31/685; A61P19/02; A61P33/12; A61P35/00; C07F9/655
Domestic Patent References:
| WO1997001548A1 | 1997-01-16 |
Foreign References:
| CN105288648A | 2016-02-03 | |||
| CN105457038A | 2016-04-06 | |||
| CN102153564A | 2011-08-17 | |||
| US20100266570A1 | 2010-10-21 | |||
| US20040072896A1 | 2004-04-15 | |||
| CN101421276A | 2009-04-29 | |||
| CN103181901A | 2013-07-03 | |||
| CN105213321A | 2016-01-06 | |||
| CN101732250A | 2010-06-16 |
Attorney, Agent or Firm:
NANJING JINGWEI PATENT & TRADEMARK AGENCY CO., LTD (CN)
Download PDF:
Previous Patent: FINE-GRAINED OBJECT RECOGNITION IN ROBOTIC SYSTEMS
Next Patent: DEVICE FOR TRANSFORMING ENERGY
Next Patent: DEVICE FOR TRANSFORMING ENERGY